• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-503通过调控程序性细胞死亡蛋白4促进结肠癌细胞的迁移和侵袭。

MiR-503 promotes the migration and invasion of colorectal cancer cells by regulating PDCD4.

作者信息

Li Lihua, Zhang Xiaolian, Yi Zengxing, Liang Xiaofang, Yin Weihua, Li Shaoyuan

机构信息

Department of Oncology, People's Hospital of Yichun, Jiangxi Province, China.

出版信息

J BUON. 2018 May-Jun;23(3):579-586.

PMID:30003722
Abstract

PURPOSE

MicroRNAs are expressed abnormally in colorectal cancer (CRC) and could participate in its development. In this study we aimed to explore the molecular mechanisms of miR-503 in the genesis of CRC.

METHODS

The relative expression of miR-503 and programmed cell death 4 (PDCD4) tumor suppressor in CRC tissues and cell lines were detected by qRT-PCR and Western blot. Cell migration and cell invasion were assessed by transwell assay. Moreover, the confirmation of the direct target of miR-503 in CRC was performed by luciferase reporter assay.

RESULTS

The expression of miR-503 was increased remarkably in CRC, while PDCD4 decreased. Moreover, PDCD4 was verified as a specific target of miR-503 in CRC and it could reverse the effect of miR-503 on CRC cells. Furthermore, the abnormal expression of miR-503 played an important role in regulating of the development of CRC cells. In addition, PDCD4 protein expression and miR-503 mRNA expression were negatively correlated in CRC tissues.

CONCLUSION

The inhibitory effect of miR-503 in CRC was realized by the upregulation of PDCD4, suggesting that miR-503/PDCD4 axis might play a critical role in CRC and could possibly be a therapeutic target.

摘要

目的

微小RNA在结直肠癌(CRC)中异常表达,并可能参与其发展。在本研究中,我们旨在探讨miR - 503在CRC发生中的分子机制。

方法

采用qRT - PCR和蛋白质免疫印迹法检测CRC组织和细胞系中miR - 503和程序性细胞死亡4(PDCD4)肿瘤抑制因子的相对表达。通过Transwell实验评估细胞迁移和侵袭能力。此外,通过荧光素酶报告基因实验验证miR - 503在CRC中的直接靶点。

结果

miR - 503在CRC中表达显著增加,而PDCD4表达降低。此外,PDCD4被证实为CRC中miR - 503的特异性靶点,并且它可以逆转miR - 503对CRC细胞的影响。此外,miR - 503的异常表达在调节CRC细胞发展中起重要作用。另外,在CRC组织中,PDCD4蛋白表达与miR - 503 mRNA表达呈负相关。

结论

miR - 503对CRC的抑制作用是通过上调PDCD4实现的,提示miR - 503/PDCD4轴可能在CRC中起关键作用,并且可能成为一个治疗靶点。

相似文献

1
MiR-503 promotes the migration and invasion of colorectal cancer cells by regulating PDCD4.微小RNA-503通过调控程序性细胞死亡蛋白4促进结肠癌细胞的迁移和侵袭。
J BUON. 2018 May-Jun;23(3):579-586.
2
miR-181b functions as an oncomiR in colorectal cancer by targeting PDCD4.微小RNA-181b通过靶向程序性细胞死亡蛋白4在结直肠癌中发挥癌基因作用。
Protein Cell. 2016 Oct;7(10):722-734. doi: 10.1007/s13238-016-0313-2. Epub 2016 Sep 19.
3
Overexpression of MEG3 sensitizes colorectal cancer cells to oxaliplatin through regulation of miR-141/PDCD4 axis.MEG3 的过表达通过调节 miR-141/PDCD4 轴使结直肠癌细胞对奥沙利铂敏感。
Biomed Pharmacother. 2018 Oct;106:1607-1615. doi: 10.1016/j.biopha.2018.07.131. Epub 2018 Jul 29.
4
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.微小RNA-21(miR-21)在转录后下调肿瘤抑制因子程序性细胞死亡蛋白4(Pdcd4),并促进结直肠癌的侵袭、血管内侵入和转移。
Oncogene. 2008 Apr 3;27(15):2128-36. doi: 10.1038/sj.onc.1210856. Epub 2007 Oct 29.
5
Circ_0003266 sponges miR-503-5p to suppress colorectal cancer progression via regulating PDCD4 expression.环状 RNA 0003266 通过调控 PDCD4 表达抑制结肠癌进展。
BMC Cancer. 2021 Mar 16;21(1):284. doi: 10.1186/s12885-021-07997-0.
6
MiR-335-5p Inhibits Cell Proliferation, Migration and Invasion in Colorectal Cancer through Downregulating LDHB.微小RNA-335-5p通过下调乳酸脱氢酶B抑制结直肠癌细胞的增殖、迁移和侵袭。
J BUON. 2019 May-Jun;24(3):1128-1136.
7
LncRNA HAND2-AS1 inhibits 5-fluorouracil resistance by modulating miR-20a/PDCD4 axis in colorectal cancer.长链非编码 RNA HAND2-AS1 通过调节 miR-20a/PDCD4 轴抑制结直肠癌细胞对 5-氟尿嘧啶的耐药性。
Cell Signal. 2020 Feb;66:109483. doi: 10.1016/j.cellsig.2019.109483. Epub 2019 Nov 21.
8
MiR-761 inhibits colorectal cancer cell proliferation and invasion through targeting HDAC1.微小RNA-761通过靶向组蛋白去乙酰化酶1抑制结肠癌细胞的增殖和侵袭。
Pharmazie. 2019 Feb 1;74(2):111-114. doi: 10.1691/ph.2019.8756.
9
MiR-155 inhibits proliferation and invasion by directly targeting PDCD4 in non-small cell lung cancer.miR-155 通过直接靶向 PDCD4 抑制非小细胞肺癌的增殖和侵袭。
Thorac Cancer. 2017 Nov;8(6):613-619. doi: 10.1111/1759-7714.12492. Epub 2017 Aug 26.
10
MicroRNA-150 promotes cell proliferation, migration, and invasion of cervical cancer through targeting PDCD4.微小 RNA-150 通过靶向 PDCD4 促进宫颈癌的细胞增殖、迁移和侵袭。
Biomed Pharmacother. 2018 Jan;97:511-517. doi: 10.1016/j.biopha.2017.09.143. Epub 2017 Nov 6.

引用本文的文献

1
The Role and Interactions of Programmed Cell Death 4 and its Regulation by microRNA in Transformed Cells of the Gastrointestinal Tract.程序性细胞死亡4在胃肠道转化细胞中的作用、相互作用及其受微小RNA的调控
Front Oncol. 2022 Jun 29;12:903374. doi: 10.3389/fonc.2022.903374. eCollection 2022.
2
Circ_0087862 promotes the progression of colorectal cancer by sponging miR-142-3p and up-regulating BACH1 expression.环状 RNA 0087862 通过海绵吸附 miR-142-3p 并上调 BACH1 表达促进结直肠癌的进展。
Kaohsiung J Med Sci. 2021 Dec;37(12):1048-1057. doi: 10.1002/kjm2.12437. Epub 2021 Aug 13.
3
Circ_0003266 sponges miR-503-5p to suppress colorectal cancer progression via regulating PDCD4 expression.
环状 RNA 0003266 通过调控 PDCD4 表达抑制结肠癌进展。
BMC Cancer. 2021 Mar 16;21(1):284. doi: 10.1186/s12885-021-07997-0.
4
MicroRNA-429 acts as a tumor suppressor in colorectal cancer by targeting high mobility group box 3.微小RNA-429通过靶向高迁移率族蛋白盒3发挥结直肠癌肿瘤抑制因子的作用。
Oncol Lett. 2021 Apr;21(4):250. doi: 10.3892/ol.2021.12511. Epub 2021 Feb 3.
5
An in silico approach to identify and prioritize miRNAs target sites polymorphisms in colorectal cancer and obesity.一种基于计算机的方法,用于鉴定和优先考虑结直肠癌和肥胖症中 miRNA 靶位点多态性。
Cancer Med. 2020 Dec;9(24):9511-9528. doi: 10.1002/cam4.3546. Epub 2020 Oct 18.
6
MicroRNA-503 serves an oncogenic role in retinoblastoma progression by directly targeting PTPN12.微小RNA-503通过直接靶向蛋白酪氨酸磷酸酶非受体型12在视网膜母细胞瘤进展中发挥致癌作用。
Exp Ther Med. 2019 Sep;18(3):2285-2292. doi: 10.3892/etm.2019.7795. Epub 2019 Jul 19.